Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Targeted Cancer Drugs market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Targeted Cancer Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Targeted Cancer Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Celgene
Vertex
AbbVie
Incyte
Eli Lilly
Teva
Galapagos
Sanofi
Gilead
Astellas Pharma
Pfizer
Novartis
By Type:
Cancer Growth Blocker Drug
Monoclonal Antibody
Other
By End-User:
Hospitals
Academic & Research Institutes
Diagnostic & Reference Laboratories
By Region:
-
Hokkaido
-
Tohoku
-
Kanto
-
Chubu
-
Kinki
-
Chugoku
-
Shikoku
-
Kyushu
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Targeted Cancer Drugs Market
-
1.3 Market Segment by Type
-
1.3.1 Japan Targeted Cancer Drugs Market Size and Growth Rate of Cancer Growth Blocker Drug from 2014 to 2026
-
1.3.2 Japan Targeted Cancer Drugs Market Size and Growth Rate of Monoclonal Antibody from 2014 to 2026
-
1.3.3 Japan Targeted Cancer Drugs Market Size and Growth Rate of Other from 2014 to 2026
-
1.4 Market Segment by Application
-
1.4.1 Market Size and Growth Rate of Hospitals
-
1.4.2 Market Size and Growth Rate of Academic & Research Institutes
-
1.4.3 Market Size and Growth Rate of Diagnostic & Reference Laboratories
-
1.5 Market Segment by Regions
-
1.5.1 Hokkaido Targeted Cancer Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Tohoku Targeted Cancer Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Kanto Targeted Cancer Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Chubu Targeted Cancer Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.5 Kinki Targeted Cancer Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.6 Chugoku Targeted Cancer Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.7 Shikoku Targeted Cancer Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.8 Kyushu Targeted Cancer Drugs Consumption Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Targeted Cancer Drugs Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Targeted Cancer Drugs by Major Types
-
3.4.1 Japan Targeted Cancer Drugs Market Size and Growth Rate of Cancer Growth Blocker Drug from 2014 to 2026
-
3.4.2 Japan Targeted Cancer Drugs Market Size and Growth Rate of Monoclonal Antibody from 2014 to 2026
-
3.4.3 Japan Targeted Cancer Drugs Market Size and Growth Rate of Other from 2014 to 2026
4 Segmentation of Targeted Cancer Drugs Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Targeted Cancer Drugs by Major End-Users
-
4.4.1 Market Size and Growth Rate of Targeted Cancer Drugs in Hospitals
-
4.4.2 Market Size and Growth Rate of Targeted Cancer Drugs in Academic & Research Institutes
-
4.4.3 Market Size and Growth Rate of Targeted Cancer Drugs in Diagnostic & Reference Laboratories
5 Market Analysis by Regions
-
5.1 Japan Targeted Cancer Drugs Production Analysis by Regions
-
5.2 Japan Targeted Cancer Drugs Consumption Analysis by Regions
6 Hokkaido Targeted Cancer Drugs Landscape Analysis
-
6.1 Hokkaido Targeted Cancer Drugs Landscape Analysis by Major Types
-
6.2 Hokkaido Targeted Cancer Drugs Landscape Analysis by Major End-Users
7 Tohoku Targeted Cancer Drugs Landscape Analysis
-
7.1 Tohoku Targeted Cancer Drugs Landscape Analysis by Major Types
-
7.2 Tohoku Targeted Cancer Drugs Landscape Analysis by Major End-Users
8 Kanto Targeted Cancer Drugs Landscape Analysis
-
8.1 Kanto Targeted Cancer Drugs Landscape Analysis by Major Types
-
8.2 Kanto Targeted Cancer Drugs Landscape Analysis by Major End-Users
9 Chubu Targeted Cancer Drugs Landscape Analysis
-
9.1 Chubu Targeted Cancer Drugs Landscape Analysis by Major Types
-
9.2 Chubu Targeted Cancer Drugs Landscape Analysis by Major End-Users
10 Kinki Targeted Cancer Drugs Landscape Analysis
-
10.1 Kinki Targeted Cancer Drugs Landscape Analysis by Major Types
-
10.2 Kinki Targeted Cancer Drugs Landscape Analysis by Major End-Users
11 Chugoku Targeted Cancer Drugs Landscape Analysis
-
11.1 Chugoku Targeted Cancer Drugs Landscape Analysis by Major Types
-
11.2 Chugoku Targeted Cancer Drugs Landscape Analysis by Major End-Users
12 Shikoku Targeted Cancer Drugs Landscape Analysis
-
12.1 Shikoku Targeted Cancer Drugs Landscape Analysis by Major Types
-
12.2 Shikoku Targeted Cancer Drugs Landscape Analysis by Major End-Users
13 Kyushu Targeted Cancer Drugs Landscape Analysis
-
13.1 Kyushu Targeted Cancer Drugs Landscape Analysis by Major Types
-
13.2 Kyushu Targeted Cancer Drugs Landscape Analysis by Major End-Users
14 Major Players Profiles
-
14.1 Celgene
-
14.1.1 Celgene Company Profile and Recent Development
-
14.1.2 Celgene Market Performance
-
14.1.3 Celgene Product and Service Introduction
-
14.2 Vertex
-
14.2.1 Vertex Company Profile and Recent Development
-
14.2.2 Vertex Market Performance
-
14.2.3 Vertex Product and Service Introduction
-
14.3 AbbVie
-
14.3.1 AbbVie Company Profile and Recent Development
-
14.3.2 AbbVie Market Performance
-
14.3.3 AbbVie Product and Service Introduction
-
14.4 Incyte
-
14.4.1 Incyte Company Profile and Recent Development
-
14.4.2 Incyte Market Performance
-
14.4.3 Incyte Product and Service Introduction
-
14.5 Eli Lilly
-
14.5.1 Eli Lilly Company Profile and Recent Development
-
14.5.2 Eli Lilly Market Performance
-
14.5.3 Eli Lilly Product and Service Introduction
-
14.6 Teva
-
14.6.1 Teva Company Profile and Recent Development
-
14.6.2 Teva Market Performance
-
14.6.3 Teva Product and Service Introduction
-
14.7 Galapagos
-
14.7.1 Galapagos Company Profile and Recent Development
-
14.7.2 Galapagos Market Performance
-
14.7.3 Galapagos Product and Service Introduction
-
14.8 Sanofi
-
14.8.1 Sanofi Company Profile and Recent Development
-
14.8.2 Sanofi Market Performance
-
14.8.3 Sanofi Product and Service Introduction
-
14.9 Gilead
-
14.9.1 Gilead Company Profile and Recent Development
-
14.9.2 Gilead Market Performance
-
14.9.3 Gilead Product and Service Introduction
-
14.10 Astellas Pharma
-
14.10.1 Astellas Pharma Company Profile and Recent Development
-
14.10.2 Astellas Pharma Market Performance
-
14.10.3 Astellas Pharma Product and Service Introduction
-
14.11 Pfizer
-
14.11.1 Pfizer Company Profile and Recent Development
-
14.11.2 Pfizer Market Performance
-
14.11.3 Pfizer Product and Service Introduction
-
14.12 Novartis
-
14.12.1 Novartis Company Profile and Recent Development
-
14.12.2 Novartis Market Performance
-
14.12.3 Novartis Product and Service Introduction
The List of Tables and Figures (Totals 81 Figures and 165 Tables)
-
Figure Japan Targeted Cancer Drugs Market Size and Growth Rate of Cancer Growth Blocker Drug from 2014 to 2026
-
Figure Japan Targeted Cancer Drugs Market Size and Growth Rate of Monoclonal Antibody from 2014 to 2026
-
Figure Japan Targeted Cancer Drugs Market Size and Growth Rate of Other from 2014 to 2026
-
Figure Market Share by Type in 2014
-
Figure Market Share by Type in 2018
-
Figure Market Share by Type in 2026
-
Figure Market Size and Growth Rate of Hospitals
-
Figure Market Size and Growth Rate of Academic & Research Institutes
-
Figure Market Size and Growth Rate of Diagnostic & Reference Laboratories
-
Figure Market Share by End-User in 2014
-
Figure Market Share by End-User in 2018
-
Figure Market Share by End-User in 2026
-
Figure Hokkaido Targeted Cancer Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Tohoku Targeted Cancer Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kanto Targeted Cancer Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chubu Targeted Cancer Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kinki Targeted Cancer Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chugoku Targeted Cancer Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Shikoku Targeted Cancer Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kyushu Targeted Cancer Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of Targeted Cancer Drugs Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2018
-
Figure Market Share of TOP 5 Players in 2018
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Targeted Cancer Drugs
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Targeted Cancer Drugs by Different Types from 2014 to 2026
-
Table Consumption Share of Targeted Cancer Drugs by Different Types from 2014 to 2026
-
Figure Japan Targeted Cancer Drugs Market Size and Growth Rate of Cancer Growth Blocker Drug from 2014 to 2026
-
Figure Japan Targeted Cancer Drugs Market Size and Growth Rate of Monoclonal Antibody from 2014 to 2026
-
Figure Japan Targeted Cancer Drugs Market Size and Growth Rate of Other from 2014 to 2026
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Targeted Cancer Drugs by Different End-Users from 2014 to 2026
-
Table Consumption Share of Targeted Cancer Drugs by Different End-Users from 2014 to 2026
-
Figure Market Size and Growth Rate of Hospitals
-
Figure Market Size and Growth Rate of Academic & Research Institutes
-
Figure Market Size and Growth Rate of Diagnostic & Reference Laboratories
-
Table Japan Targeted Cancer Drugs Production by Regions
-
Table Japan Targeted Cancer Drugs Production Share by Regions
-
Figure Japan Targeted Cancer Drugs Production Share by Regions in 2014
-
Figure Japan Targeted Cancer Drugs Production Share by Regions in 2018
-
Figure Japan Targeted Cancer Drugs Production Share by Regions in 2026
-
Table Japan Targeted Cancer Drugs Consumption by Regions
-
Table Japan Targeted Cancer Drugs Consumption Share by Regions
-
Figure Japan Targeted Cancer Drugs Consumption Share by Regions in 2014
-
Figure Japan Targeted Cancer Drugs Consumption Share by Regions in 2018
-
Figure Japan Targeted Cancer Drugs Consumption Share by Regions in 2026
-
Table Hokkaido Targeted Cancer Drugs Consumption by Types from 2014 to 2026
-
Table Hokkaido Targeted Cancer Drugs Consumption Share by Types from 2014 to 2026
-
Figure Hokkaido Targeted Cancer Drugs Consumption Share by Types in 2014
-
Figure Hokkaido Targeted Cancer Drugs Consumption Share by Types in 2018
-
Figure Hokkaido Targeted Cancer Drugs Consumption Share by Types in 2026
-
Table Hokkaido Targeted Cancer Drugs Consumption by End-Users from 2014 to 2026
-
Table Hokkaido Targeted Cancer Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Hokkaido Targeted Cancer Drugs Consumption Share by End-Users in 2014
-
Figure Hokkaido Targeted Cancer Drugs Consumption Share by End-Users in 2018
-
Figure Hokkaido Targeted Cancer Drugs Consumption Share by End-Users in 2026
-
Table Tohoku Targeted Cancer Drugs Consumption by Types from 2014 to 2026
-
Table Tohoku Targeted Cancer Drugs Consumption Share by Types from 2014 to 2026
-
Figure Tohoku Targeted Cancer Drugs Consumption Share by Types in 2014
-
Figure Tohoku Targeted Cancer Drugs Consumption Share by Types in 2018
-
Figure Tohoku Targeted Cancer Drugs Consumption Share by Types in 2026
-
Table Tohoku Targeted Cancer Drugs Consumption by End-Users from 2014 to 2026
-
Table Tohoku Targeted Cancer Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Tohoku Targeted Cancer Drugs Consumption Share by End-Users in 2014
-
Figure Tohoku Targeted Cancer Drugs Consumption Share by End-Users in 2018
-
Figure Tohoku Targeted Cancer Drugs Consumption Share by End-Users in 2026
-
Table Kanto Targeted Cancer Drugs Consumption by Types from 2014 to 2026
-
Table Kanto Targeted Cancer Drugs Consumption Share by Types from 2014 to 2026
-
Figure Kanto Targeted Cancer Drugs Consumption Share by Types in 2014
-
Figure Kanto Targeted Cancer Drugs Consumption Share by Types in 2018
-
Figure Kanto Targeted Cancer Drugs Consumption Share by Types in 2026
-
Table Kanto Targeted Cancer Drugs Consumption by End-Users from 2014 to 2026
-
Table Kanto Targeted Cancer Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Kanto Targeted Cancer Drugs Consumption Share by End-Users in 2014
-
Figure Kanto Targeted Cancer Drugs Consumption Share by End-Users in 2018
-
Figure Kanto Targeted Cancer Drugs Consumption Share by End-Users in 2026
-
Table Chubu Targeted Cancer Drugs Consumption by Types from 2014 to 2026
-
Table Chubu Targeted Cancer Drugs Consumption Share by Types from 2014 to 2026
-
Figure Chubu Targeted Cancer Drugs Consumption Share by Types in 2014
-
Figure Chubu Targeted Cancer Drugs Consumption Share by Types in 2018
-
Figure Chubu Targeted Cancer Drugs Consumption Share by Types in 2026
-
Table Chubu Targeted Cancer Drugs Consumption by End-Users from 2014 to 2026
-
Table Chubu Targeted Cancer Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Chubu Targeted Cancer Drugs Consumption Share by End-Users in 2014
-
Figure Chubu Targeted Cancer Drugs Consumption Share by End-Users in 2018
-
Figure Chubu Targeted Cancer Drugs Consumption Share by End-Users in 2026
-
Table Kinki Targeted Cancer Drugs Consumption by Types from 2014 to 2026
-
Table Kinki Targeted Cancer Drugs Consumption Share by Types from 2014 to 2026
-
Figure Kinki Targeted Cancer Drugs Consumption Share by Types in 2014
-
Figure Kinki Targeted Cancer Drugs Consumption Share by Types in 2018
-
Figure Kinki Targeted Cancer Drugs Consumption Share by Types in 2026
-
Table Kinki Targeted Cancer Drugs Consumption by End-Users from 2014 to 2026
-
Table Kinki Targeted Cancer Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Kinki Targeted Cancer Drugs Consumption Share by End-Users in 2014
-
Figure Kinki Targeted Cancer Drugs Consumption Share by End-Users in 2018
-
Figure Kinki Targeted Cancer Drugs Consumption Share by End-Users in 2026
-
Table Chugoku Targeted Cancer Drugs Consumption by Types from 2014 to 2026
-
Table Chugoku Targeted Cancer Drugs Consumption Share by Types from 2014 to 2026
-
Figure Chugoku Targeted Cancer Drugs Consumption Share by Types in 2014
-
Figure Chugoku Targeted Cancer Drugs Consumption Share by Types in 2018
-
Figure Chugoku Targeted Cancer Drugs Consumption Share by Types in 2026
-
Table Chugoku Targeted Cancer Drugs Consumption by End-Users from 2014 to 2026
-
Table Chugoku Targeted Cancer Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Chugoku Targeted Cancer Drugs Consumption Share by End-Users in 2014
-
Figure Chugoku Targeted Cancer Drugs Consumption Share by End-Users in 2018
-
Figure Chugoku Targeted Cancer Drugs Consumption Share by End-Users in 2026
-
Table Shikoku Targeted Cancer Drugs Consumption by Types from 2014 to 2026
-
Table Shikoku Targeted Cancer Drugs Consumption Share by Types from 2014 to 2026
-
Figure Shikoku Targeted Cancer Drugs Consumption Share by Types in 2014
-
Figure Shikoku Targeted Cancer Drugs Consumption Share by Types in 2018
-
Figure Shikoku Targeted Cancer Drugs Consumption Share by Types in 2026
-
Table Shikoku Targeted Cancer Drugs Consumption by End-Users from 2014 to 2026
-
Table Shikoku Targeted Cancer Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Shikoku Targeted Cancer Drugs Consumption Share by End-Users in 2014
-
Figure Shikoku Targeted Cancer Drugs Consumption Share by End-Users in 2018
-
Figure Shikoku Targeted Cancer Drugs Consumption Share by End-Users in 2026
-
Table Kyushu Targeted Cancer Drugs Consumption by Types from 2014 to 2026
-
Table Kyushu Targeted Cancer Drugs Consumption Share by Types from 2014 to 2026
-
Figure Kyushu Targeted Cancer Drugs Consumption Share by Types in 2014
-
Figure Kyushu Targeted Cancer Drugs Consumption Share by Types in 2018
-
Figure Kyushu Targeted Cancer Drugs Consumption Share by Types in 2026
-
Table Kyushu Targeted Cancer Drugs Consumption by End-Users from 2014 to 2026
-
Table Kyushu Targeted Cancer Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Kyushu Targeted Cancer Drugs Consumption Share by End-Users in 2014
-
Figure Kyushu Targeted Cancer Drugs Consumption Share by End-Users in 2018
-
Figure Kyushu Targeted Cancer Drugs Consumption Share by End-Users in 2026
-
Table Company Profile and Development Status of Celgene
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celgene
-
Figure Sales and Growth Rate Analysis of Celgene
-
Figure Revenue and Market Share Analysis of Celgene
-
Table Product and Service Introduction of Celgene
-
Table Company Profile and Development Status of Vertex
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vertex
-
Figure Sales and Growth Rate Analysis of Vertex
-
Figure Revenue and Market Share Analysis of Vertex
-
Table Product and Service Introduction of Vertex
-
Table Company Profile and Development Status of AbbVie
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie
-
Figure Sales and Growth Rate Analysis of AbbVie
-
Figure Revenue and Market Share Analysis of AbbVie
-
Table Product and Service Introduction of AbbVie
-
Table Company Profile and Development Status of Incyte
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Incyte
-
Figure Sales and Growth Rate Analysis of Incyte
-
Figure Revenue and Market Share Analysis of Incyte
-
Table Product and Service Introduction of Incyte
-
Table Company Profile and Development Status of Eli Lilly
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly
-
Figure Sales and Growth Rate Analysis of Eli Lilly
-
Figure Revenue and Market Share Analysis of Eli Lilly
-
Table Product and Service Introduction of Eli Lilly
-
Table Company Profile and Development Status of Teva
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva
-
Figure Sales and Growth Rate Analysis of Teva
-
Figure Revenue and Market Share Analysis of Teva
-
Table Product and Service Introduction of Teva
-
Table Company Profile and Development Status of Galapagos
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Galapagos
-
Figure Sales and Growth Rate Analysis of Galapagos
-
Figure Revenue and Market Share Analysis of Galapagos
-
Table Product and Service Introduction of Galapagos
-
Table Company Profile and Development Status of Sanofi
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi
-
Figure Sales and Growth Rate Analysis of Sanofi
-
Figure Revenue and Market Share Analysis of Sanofi
-
Table Product and Service Introduction of Sanofi
-
Table Company Profile and Development Status of Gilead
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gilead
-
Figure Sales and Growth Rate Analysis of Gilead
-
Figure Revenue and Market Share Analysis of Gilead
-
Table Product and Service Introduction of Gilead
-
Table Company Profile and Development Status of Astellas Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma
-
Figure Sales and Growth Rate Analysis of Astellas Pharma
-
Figure Revenue and Market Share Analysis of Astellas Pharma
-
Table Product and Service Introduction of Astellas Pharma
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
